Search Results - "Ciorra, A A"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Troponin I and B-type Natriuretic Peptide (BNP) as biomarkers for the prediction of cardiotoxicity in patients with breast cancer treated with adjuvant anthracyclines and trastuzumab by Pistillucci, G, Ciorra, A A, Sciacca, V, Raponi, M, Rossi, R, Veltri, E

    Published in Clinica terapeutica (2015)
    “…Adjuvant trastuzumab with chemotherapy is the treatment of choice for patients with human epidermal growth factor receptor positive (HER2+) breast cancer and…”
    Get more information
    Journal Article
  2. 2

    Long-term Survival of Metastatic Melanoma to the Ileum with Evidence of Primary Cutaneous Disease after 15 years of follow-up: A Case Report by Sciacca, Venerina, Ciorra, A Alida, Di Fonzo, Concetta, Rossi, Rosalinda, Pistillucci, Giorgio, Lugini, Antonio, D'Aprile, Modesto

    Published in Tumori (01-07-2010)
    “…The small bowel is the most common site of gastrointestinal metastasis from cutaneous melanoma. Malignant melanoma has a poor prognosis, especially if distant…”
    Get full text
    Journal Article
  3. 3

    Unusual endotracheal and breast metastasis from renal clear cell carcinoma: a case report by Ciorra, A A, Sciacca, V, Pistillucci, G, Rossi, R, Di Palma, T, Travaini, S, Ricci, F, Veltri, E

    Published in Clinica terapeutica (01-01-2013)
    “…We report a case of a woman affected by a metastatic renal clear cell carcinoma who showed unusual metastasis into the trachea and in the right breast 17 years…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Carboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II study by Recchia, F, De Filippis, S, Pompili, P L, Rosselli, M, Saggio, G, Ciorra, A, Piccinini, M, Rea, S

    Published in Clinica terapeutica (01-07-1999)
    “…Carboplatin, vindesine and 5-fluorouracil/leucovorin are drugs active in the treatment of non-small cell lung cancer (NSCLC) and they can be administered in an…”
    Get more information
    Journal Article
  9. 9

    Bisphosphonates and Oral Cavity Avascular Bone Necrosis: A Review of Twelve Cases by SALESI, Nello, PISTILLI, Roberto, DI FONSO, Concetta, CORTESI, Enrico, VELTRI, Enzo, VECCHIONE, Aldo, MARCELLI, Vincenzo, GOVONI, Flavio Andrea, BOZZA, Fabrizio, BOSSONE, Giandominik, VENTURELLI, Viola, DI COCCO, Barbara, PACETTI, Umberto, CIORRA, Alida

    Published in Anticancer research (01-07-2006)
    “…Background: Intravenous bisphosphonates are the current standard of care for the treatment of hypercalcemia of malignancy and for the prevention of skeletal…”
    Get full text
    Journal Article
  10. 10

    Bisphosphonates and oral cavity avascular bone necrosis: A review of 12 cases by Salesi, N., Pistilli, R., Marcelli, V., Govoni, F. A., Di Cocco, B., Pacetti, U., Di Fonso, C., Ciorra, A., Natali, M., Veltri, E.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 18628 Background: Intravenous bisphosphonates are the current standard of care for the treatment of hypercalcemia of malignancy and for the…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    In-vitro action of manganese on platelet aggregation. Hints on prevention by Fimiani, R, Serpico, P, Ciorra, A

    Published in Giornale italiano di medicina del lavoro (01-11-1982)
    “…The AA. carried out some researches on PAT by adding to the plasma the manganic chloride in mu molar, c molar and m molar solution. The platelet aggregation…”
    Get more information
    Journal Article